載入...
High-Dose CD20-Targeted Radioimmunotherapy-Based Autologous Transplantation Improves Outcomes for Persistent Mantle Cell Lymphoma
Autologous stem cell transplant (ASCT) can improve outcomes for mantle cell lymphoma (MCL) patients, yet relapses are frequent. We hypothesized that high-dose anti-CD20 radioimmunotherapy (RIT)-based conditioning could improve results in this setting. We thus assessed 162 consecutive patients with M...
Na minha lista:
發表在: | Br J Haematol |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
2015
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4715476/ https://ncbi.nlm.nih.gov/pubmed/26455717 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.13773 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|